Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human Vaccines & Immunotherapeutics

• Publication date

  2012-04-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.4161/hv.19684PMID 22495117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

  2011cited by this paper
• Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial.

  2011cited by this paper
• Structural basis of influenza virus neutralization

  2011cited by this paper
• A Phase III Evaluation of Immunogenicity and Safety of Two Trivalent Inactivated Seasonal Influenza Vaccines in US Children

  2010cited by this paper
• Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

  2010cited by this paper
• Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

  2010cited by this paper
• A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults

  2010cited by this paper
• Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

  2010cited by this paper
• An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers.

  2010cited by this paper
• Immunogenicity and safety of a novel AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan

  2010influential reference
• Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children

  2010cited by this paper
• Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

  2010cited by this paper
• Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

  2010cited by this paper
• Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan

  2009cited by this paper
• Critically Ill patients with 2009 influenza A(H1N1) in Mexico.

  2009cited by this paper
• Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults.

  2009cited by this paper
• Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

  2009cited by this paper
• Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

  2009cited by this paper
• 2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009.

  2009cited by this paper
• Pandemic influenza A (H1N1) 2009 virus vaccine - conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts.

  2009cited by this paper
• Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans

  2009cited by this paper
• Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine

  2008cited by this paper
• Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

  2007cited by this paper
• Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6-9 and 10-13 years.

  2007cited by this paper
• Influenza-Related Hospitalizations in Children Younger Than Three Years of Age

  2006cited by this paper
• Ten Years of Experience with the Trivalent Split-Influenza Vaccine, Fluarix™

  2002cited by this paper
• Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro.

  1999cited by this paper
• Available From

  1973cited by this paper

• Low hemagglutinin antigen dose influenza vaccines adjuvanted with AS03 alter the long-term immune responses in BALB/c mice

  2017cites this paper
• AS03- and MF59-Adjuvanted Influenza Vaccines in Children

  2017cites this paper
• Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine

  2016cites this paper
• Evaluation of estimated number of influenza patients from national sentinel surveillance using the national database of electronic medical claims.

  2015cites this paper
• Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains

  2015cites this paper
• An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age.

  2014cites this paper
• 2012 Antigen Review for the New Zealand National Immunisation Schedule: Influenza

  2013cites this paper
• Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine

  2013cites this paper
• Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

  2013cites this paper
• Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season

  2012cites this paper